PharmiWeb12d
ICON portfolio of AI tools drives clinical trial efficiencies
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced ...
Contract Pharma12d
ICON Expands Portfolio of AI Tools
ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...
Royalty Pharma sees FY25 portfolio receipts $2.9B-$3.05B
Royalty Pharma (RPRX) expects 2025 Portfolio Receipts to be between $2,900 million and $3,050 million, representing expected growth of 4% to ...
Morningstar13d
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI ...